On ECHEMI
Home > Drugs > Jiangsu Yabang Translation Love Posen Pharmaceutical Co., Ltd.
Jiangsu Yabang Translation Love Posen Pharmaceutical Co., Ltd.
  • Founded in:

    2001-01-17
  • Country:

    China China
  • Address:

    Yancheng Xiangshui County Economic Development Zone
  • Tax NO.:

    91320921703859698E
  • Registered Funds:

    40 million yuan
  • Website:

  • Email:

Related Drugs
Metronidazole capsules
Name Description Content CAS NO. Registered Holders
Metronidazole

Extract from the above information

More

Extract from the above information

443-48-1 39
Clonidine Hydrochloride Tablets
The main ingredient and chemical name of this product are: [2-(2,6-dichlorophenyl)imino]imidazolidine hydrochloride
Name Description Content CAS NO. Registered Holders
Clonidine hydrochloride

Clonidine is an alpha receptor agonist. Clonidine directly stimulates the alpha 2 receptors on the central postsynaptic membrane of the hypothalamus and medulla oblongata, excites inhibitory neurons, reduces the outflow of central sympathetic nerve impulses, and thus inhibits peripheral sympathetic nerve activity. Clonidine also stimulates the alpha 2 receptors on the presynaptic membrane of peripheral sympathetic nerves, enhancing their negative feedback, reducing the release of norepinephrine from peripheral nerve terminals, reducing peripheral vascular and renal vascular resistance, slowing heart rate, and lowering blood pressure. Renal blood flow and glomerular filtration rate remain essentially unchanged. Orthostatic symptoms are mild or less common, and postural hypotension rarely occurs. Clonidine hydrochloride causes a moderate decrease (15%~20%) in supine cardiac output without changing peripheral vascular resistance; a slight decrease in 45° tilt

More

Clonidine is an alpha receptor agonist. Clonidine directly stimulates the alpha 2 receptors on the central postsynaptic membrane of the hypothalamus and medulla oblongata, excites inhibitory neurons, reduces the outflow of central sympathetic nerve impulses, and thus inhibits peripheral sympathetic nerve activity. Clonidine also stimulates the alpha 2 receptors on the presynaptic membrane of peripheral sympathetic nerves, enhancing their negative feedback, reducing the release of norepinephrine from peripheral nerve terminals, reducing peripheral vascular and renal vascular resistance, slowing heart rate, and lowering blood pressure. Renal blood flow and glomerular filtration rate remain essentially unchanged. Orthostatic symptoms are mild or less common, and postural hypotension rarely occurs. Clonidine hydrochloride causes a moderate decrease (15%~20%) in supine cardiac output without changing peripheral vascular resistance; a slight decrease in 45° tilt

4205-91-8 23
Sildenafil Citrate Tablets
Name Description Content CAS NO. Registered Holders
Sildenafil citrate

Extract from the above information

More

Extract from the above information

171599-83-0 66
Sildenafil Citrate Tablets
Sildenafil citrate. Molecular weight: C22H30N6O4S·C6H8O7
Name Description Content CAS NO. Registered Holders
Sildenafil citrate

This product is an oral drug for the treatment of erectile dysfunction. It is a selective inhibitor of cyclic guanosine monophosphate (cGMP)-specific phosphodiesterase type 5 (PDE5). By inhibiting phosphodiesterase type 5 (PDE5) that breaks down cGMP in the corpus cavernosum, it increases the level of cGMP in the corpus cavernosum, relaxes smooth muscles, and allows blood to flow into the corpus cavernosum, exerting its effect during sexual stimulation.

More

This product is an oral drug for the treatment of erectile dysfunction. It is a selective inhibitor of cyclic guanosine monophosphate (cGMP)-specific phosphodiesterase type 5 (PDE5). By inhibiting phosphodiesterase type 5 (PDE5) that breaks down cGMP in the corpus cavernosum, it increases the level of cGMP in the corpus cavernosum, relaxes smooth muscles, and allows blood to flow into the corpus cavernosum, exerting its effect during sexual stimulation.

171599-83-0 66
Sildenafil Citrate Tablets
Sildenafil citrate. Molecular weight: C22H30N6O4S·C6H8O7
Name Description Content CAS NO. Registered Holders
Sildenafil citrate

This product is an oral medication for the treatment of erectile dysfunction. It is the citrate of sildenafil, a selective inhibitor of cyclic guanosine monophosphate (cGMP)-specific phosphodiesterase type 5 (PDE5). It enhances the effect of nitric oxide (NO) by inhibiting phosphodiesterase type 5 (PDE5) that breaks down cGMP in the corpus cavernosum, increases the level of cGMP in the corpus cavernosum during sexual stimulation, relaxes smooth muscles, and blood flows into the corpus cavernosum. In the absence of sexual stimulation, the recommended dose of sildenafil has no effect.

More

This product is an oral medication for the treatment of erectile dysfunction. It is the citrate of sildenafil, a selective inhibitor of cyclic guanosine monophosphate (cGMP)-specific phosphodiesterase type 5 (PDE5). It enhances the effect of nitric oxide (NO) by inhibiting phosphodiesterase type 5 (PDE5) that breaks down cGMP in the corpus cavernosum, increases the level of cGMP in the corpus cavernosum during sexual stimulation, relaxes smooth muscles, and blood flows into the corpus cavernosum. In the absence of sexual stimulation, the recommended dose of sildenafil has no effect.

171599-83-0 66
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.